← Insider buys
SYRS

Syros Pharmaceuticals, Inc. · Healthcare

Director Srinivas Akkaraju sold $51K of Syros Pharmaceuticals, Inc.

Sold$50,966
$11.01Price
4,627Shares

What SYRS did after the filing

Prices for SYRS after this filing aren't in yet.

Traded Wed, Jul 1. Filed Mon, Jul 6, 12:00 PM ET, during the session. Not investment advice.